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A reliable method for quantification 
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Abstract 
Background: The majority of protein isoforms arise from alternative splicing of the encoding primary RNA tran-
scripts. To understand the significance of single splicing events, reliable techniques are needed to determine their 
incidence. However, existing methods are labour-intensive, error-prone or of limited use.
Results: Here, we present an improved method to determine the relative incidence of transcripts that arise from 
alternative splicing at a single site. Splice variants were quantified within a single sample using one-step reverse tran-
scription quantitative PCR. Amplification products obtained with variant specific primer pairs were compared to those 
obtained with primer pairs common to both variants. The identities of variant specific amplicons were simultaneously 
verified by melt curve analysis. Independent calculations of the relative incidence of each variant were performed. 
Since the relative incidences of variants have to add upto 100 %, the method provides an internal control to moni-
tor experimental errors and uniform reverse transcription. The reliability of the method was tested using mixtures of 
cDNA templates as well as RNA samples from different sources.
Conclusion: The method described here, is easy to set up and does not need unrelated reference genes and time 
consuming, error-prone standard curves. It provides a reliable and precise technique to distinguish small differences 
of the relative incidence of two splice variants.
© 2016 Camacho Londono and Philipp. This article is distributed under the terms of the Creative Commons Attribution 4.0 Inter-
national License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction 
in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Com-
mons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecom-
mons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Ninety-two to ninety-four percent of the human genes 
express primary RNA transcripts that undergo alterna-
tive splicing [1]. This provides an extensive collection 
of protein isoforms that display different properties and 
serve a huge variety of functions [2]. This way, alternative 
splicing is one of the main mechanisms to expand bio-
logical diversity. It is a tightly regulated process and splic-
ing errors cause a number of human diseases [3]. RNA 
splicing is cell type specific and influenced by a number 
of external factors such us toxins or drugs. A number of 
splice variants exhibit different drug sensitivities which 
offers new perspectives for pharmacological intervention 
[4]. To investigate the significance of splicing and the role 
of each isoform, a well-founded knowledge of the inci-
dence of alternatively spliced transcripts in a defined cell 
type or tissue is indispensable.
In the last few years, RNA sequencing has become a 
valuable tool for the detection of alternative splicing due 
to increasing capacities, declining costs and newly devel-
oped statistical methods [5, 6]. In spite of that, real-time 
reverse transcription quantitative polymerase chain reac-
tion (real time RT-qPCR) is still regarded as the gold 
standard to compare the number of mRNA transcripts of 
different genes [7–10] or alternatively spliced transcripts 
of a single gene [11, 12]. However, existing methods to 
quantify the relative ratio of alternative transcripts by 
RT-qPCR are laborious, error-prone or of limited use.
A recently published method allows the relative quan-
tification of isoforms in two different samples [12]. How-
ever, highly different expression levels of each isoform 
are a prerequisite for its use [12]. This method is appli-
cable to variants that carry unique sequence informa-
tion each, but not to the majority of variants differing 
only by the presence or absence of one single exon or a 
part of it. Finally, it does not allow the quantification of 
spliced transcripts in a single sample and requires stably 
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expressed reference genes. Therefore, it is only suited for 
a limited number of applications.
In a pioneer work, Vandenbroucke and collaborators 
introduced real-time RT-qPCR as an appropriate tool to 
quantify splice variants [11]. They proposed the use of 
two primer pairs, each specific for one single variant and 
they showed that a strategy using a boundary spanning 
primer is superior to a boundary spanning TaqMan probe 
for the identification of a spliced isoform. However, the 
use of boundary spanning primers may still lead to false 
positives and reduced fidelity because of the high degree 
of similarity between the exon–exon junction sequences 
of differentially spliced mRNAs. Furthermore, the strat-
egy did not consider variations of reverse transcription 
due to different secondary structures of mRNA isoforms. 
Finally, the method was based on time consuming cDNA 
standard curves and different amplification efficiencies of 
the reactions were not considered.
Here we present an improved and reliable method to 
quantify the ratio of splice variants in a single sample 
based on RT-qPCR. In addition to two variant specific 
primer pairs, a further primer pair was introduced. Such 
control primers anneal to the transcripts of both splice 
variants, providing an internal control of the procedure. 
They may flank the splice site, enabling simultaneous 
identification of both isoforms. Reverse transcription and 
polymerase chain reaction take place in one single reac-
tion tube (one-step RT-PCR) facilitating the procedure 
and reducing the risk of technical variations. The new 
method requires neither an external reference gene nor 
standard curves. It provides great flexibility regarding the 




To test our new method, we designed primers for the 
cDNA sequences JX644971 and JX644976 of two Tran-
sient Receptor Potential Melastatin 3 (TRPM3) variants 
using the program Primer-BLAST, available online at 
http://www.ncbi.nlm.nih.gov/tools/primer-blast/. All 
primers met the requirements of the default settings, 
which were modified as follows: Their melting tempera-
tures were calculated to 72 ± 0.6 °C. All primers showed 
a GC content of 40–60 % with a GC clamp of at least two 
nucleotides. The primer pair specificity was analysed 
using the reference sequence database of Mus muscu-
lus (taxid: 10090). All primers showed a maximal self-
complementarity of eight nucleotides and a maximal 3′ 
end complementarity of three nucleotides. Primers had 
at least four total mismatches to unintended targets, 
including at least three mismatches within the last four 
base pairs (bp) at the 3′ end. Primers of each pair derived 
from separate exons to exclude PCR products of genomic 
origin. The maximal amplicon size of a primer pair was 
below 210  bp. Misprimed off-target PCR products had 
to differ in size by at least 10,000  bp. Furthermore, the 
annealing regions of all primers were checked for single 
nucleotide polymorphisms and formation of hairpins 
using the in silico evaluation tools of the RTPrimerDB 
database (http://www.rtprimerdb.org [13]). The follow-
ing HPLC-purified primers were purchased from Euro-
fins MWG Operon (Germany): control2, forward 5´ TCG 
CTC GCA GCC AGA TCT TTA TTT A, reverse 5´ GGT 
ACA ATG TAT TTG AGG GCC CAT GTC; control1, 
forward 5´ AGC CTG GAA CAG AGT TGA CAT CGC, 
reverse 5´ TCT GTC CAG GAC TAG GGC ATC CAG; 
+13, forward 5´ GCA TGC ACC GTT TTC TCA CC 
ATC, reverse 5´ GGT ACA ATG TAT TTG AGG GCC 
CAT GTC; Δ13, forward 5´ TGG AAC AGA GTT GAC 
ATC GCT CG, reverse 5´ TGA GGG CCC ATG TCT 
TCC ATT TTC.
Sample acquisition, RNA extraction and quality control
C57BL/6-129/SvJ hybrid mice were killed by cervical dis-
location. Their entire brains (n  =  3) were immediately 
isolated, snap frozen in liquid nitrogen, stored at −80 °C 
and used for experiments within 4 weeks. Choroid plexi 
isolated from six C57BL/6-129/SvJ hybrids, were shortly 
rinsed with ice-cold, sterile phosphate buffered saline 
(PBS). Three of them were pooled (n =  2), snap frozen 
in liquid nitrogen and stored at −80  °C not longer than 
10  weeks. For experiments, frozen samples were imme-
diately resuspended in peqGOLD RNAPure® reagent 
(Peqlab, Erlangen Germany) and total RNA was extracted 
following the instructions of the manufacturer. The iso-
lated RNA was further purified by four additional extrac-
tion steps using one volume of diethyl ether followed 
by ethanol precipitation using 0.3  M potassium acetate. 
For all extraction steps RNase-free/DNase-free plas-
ticware and solutions were used. Isolated RNA samples 
were dissolved in DEPC treated water, stored in aliquots 
at −80  °C and thawed only once for one-step RT-qPCR 
analysis. According to the guidelines for the publication 
of RT-qPCR experiments [14, 15] the quantity, purity and 
integrity of all used RNA stocks and dilutions were con-
trolled by spectrophotometry (Nanodrop 1000; Thermo 
Scientific) and microfluidic analysis using a Bioanalyzer 
2100 ([16], Agilent Technologies, Böblingen, Germany). 
For the microfluidic analysis the Agilent RNA 6000 
Nano Kit was used according to the instructions of the 
manufacturer after decontaminating the electrodes with 
RNase ZAP (Agilent Technologies, Böblingen, Germany). 
The different preparations had A260/A280 values between 
1.8–2.1 and A260/A230 ratios above 2. The preparations 
showed high RNA integrity with RNA integrity numbers 
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(RIN) between 8.2–8.4 for brain RNA and 9.1–9.2 for 
choroid plexus RNA.
Plasmid construction and storage
PCAGGSM2-IRESGFP plasmids [17] containing the 
cDNA of either variant 1 (GenBank accession JX644976) 
or variant 2 (GenBank accession JX644971) in the EcoRV 
site of the polylinker sequence were prepared using the 
EndoFree Plasmid Maxi Kit (Qiagen, Hilden) and stored 
in 50 µg aliquots at −20 °C. Plasmid concentrations were 
measured using the Nanodrop 1000 spectrophotometer. 
Molar concentrations were calculated using the molecu-
lar mass of each plasmid determined with the sequence 
manipulation suite (http://www.ualberta.ca/~stothard/
javascript/dna_mw.html).
Real‑time polymerase chain reaction
RT-qPCR of RNA (30  ng) or quantitative PCR of 
cDNA samples were performed at least in triplicate at 
a RotorGene 6000 real-time analyzer (Qiagen, Hilden, 
Germany). Unless otherwise indicated, 2.5  pM mix-
tures of the two plasmids described above were used. 
Unless otherwise indicated, we used the SensiMix™ 
One-step Kit (Quantace, London, U.K.). In a total vol-
ume of 10  µl we added the template, 5  µl SensiMix™ 
one-step reagent, containing reaction buffer, reverse 
transcriptase, heat activated DNA polymerase, dNTPs, 
internal reference, stabilizers and 6 mM MgCl2, 0.2 µl 
SYBR Green solution (50×; Quantace, London, U.K.) 
and 300 nM of each primer. Then, the following cycling 
profile was applied: reverse transcription for 30 min at 
45  °C (for RNA samples only) followed by incubation 
for 10  min at 95  °C. For amplification, 30–40 cycles 
were performed each with incubation at 95 °C for 15 s, 
followed by 12  s at 68  °C and 15  s at 72  °C. In some 
cases we used the Express One-Step SYBR GreenER 
Kit (Life technologies). In a total volume of 10  µl, we 
added the template, 5  µl SuperMix Universal, 0.25  µl 
SuperScript Mix and 300 nM of each primer, and then 
the following cycling profile was applied: 5 min/60  °C 
(RNA only); 2  min/95  °C; 35–40 cycles of 95  °C/15  s, 
62 °C/40 s.
Calculation of the relative incidence of spliced transcripts
The basic equation of PCR amplification presents the 
relation of the number of amplicon molecules (NCq) 
obtained at the quantification cycle (Cq) and the initial 
number of target molecules (N0).
Since this equation is valid only for an ideal amplification 
with a perfect doubling of each amplicon from cycle to 
cycle, the Cq value was replaced by an efficiency (E, with 
(1)Ncq = N0 · 2Cq
1 ≤ E ≤ 2) corrected Cq value (CqE) calculated as recom-
mended [18].
This led to Eq. (3).
Unless otherwise indicated, PCR efficiencies of each indi-
vidual reaction were calculated with the comparative 
quantitation tool of the RotorGene 6000 analysis soft-
ware [19]. The comparative quantitation (CQ) method 
uses the second derivative of raw fluorescence values—
i.e. the slope of the amplification curve—to calculate 
both, the efficiency and the take off point at which the 
exponential phase of amplification begins [19]. This take 
off point was used as Cq value [19].
Those data were compared to efficiency values obtained 
with the LinRegPCR program [20]) or with standard 
curves using the equation E  =  10−1/M with M as slope 
of the standard curve. Efficiency values of technical rep-
licates obtained by the comparative quantitation or the 
LinReg tool were averaged to the mean efficiency per 
amplicon, prior to calculate efficiency corrected Cq values. 
Rearrangement of Eq. (3) provided the mathematical rela-
tionship between the initial number of target molecules 
and the number of amplicons at the quantification cycle.
For relative quantification, we normalized the number 
of target molecules of a single splice variant to control 
amplicons (1 or 2) of transcripts of the very same gene 
and the very same sample (Fig. 1b). In contrast to unre-
lated reference genes, which are generally used for nor-
malization, these amplicons provide the most reliable 
reference possible, since their abundance is strictly linked 
to the abundance of the splice variant in the given sam-
ple. The relative incidence of a single splice variant (RIV) 
is defined as the initial amount of a single splice variant 
[N0 (var)] relative to the initial amount of the control [N0 
(con)] and can be presented as
Since the reactions were performed in parallel at the 
same PCR instrument the number of both amplicons 
obtained at the Cq (NCq) was identical. Therefore the 
equation could be simplified:
(2)CqE = Cq · log (E)
/
log (2)
(3)Ncq = N0 · 2cq·log (E)/ log (2)
(4)N0 = Ncq
/
2cq·log (E)/ log (2)
(5)
RIV = N0(var)/N0(con)





= 2Cqcon·log(Econ)/ log (2) - Cqvar·log (Evar)/ log (2)
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Finally, the value was scaled to percentage, to allow com-
parison of the relative incidence of a single splice variant 
between different samples:
Since the two different splice variants derive from the 
same pre-mRNA and are mutually exclusive, their rela-
tive incidences to the control amplicon of the same tran-
script (RIVs) had to add up to 100 %.
This way of analysis provided a unique and easy control 
for the correctness of the calculation.
Analysis of the amplification products
The identity of the PCR products and their purity in each 
sample were controlled after the last amplification cycle 
by melting curve analysis. In some cases, the results were 
confirmed by gel electrophoresis. For melting curve anal-
ysis, SYBRGreen stained products were kept at 60 °C for 
90 s and melted by raising the temperature by 0.3 °C per 
second up to 95 °C. Products stained with SYBRGreenER 
were analysed with a similar protocol but with a rate of 
0.2 °C per second.
Statistical analysis
Mean data are given ±SE. Statistical significance of 
differences between the starting amount of control2 
(defined as 100  %) and control1, control2 and variant2 
and control2 and variant1 were determined using the 
unpaired, two-tailed students t test (*p < 0.05, **p < 0.01, 
***p  <  0.001, ns not significantly different p  >  0.05). All 
tests were performed using Microsoft Excel.
Results and discussion
Strategy of the method
To determine the relative incidence of two splice variants 
the method of choice should be reliable and as simple as 
possible. To meet these requirements, our strategy was 
based on five key elements (Fig. 1a).
1. For the sake of simplicity and robustness, we used 
one-step RT-PCR with gene specific priming of reverse 
transcription. In one-step RT-PCR, reverse transcription 
is carried out in the same tube as the PCR reaction. It is 
easy to install, involves less error-prone working steps 
and reduces the risk of contamination [21].
2. We chose SYBR Green staining of DNA amplicons 
as method of detection. SYBR Green binds to double 
stranded DNA and is an economical and well-established 





= 2Cqcon·log(Econ)/ log (2) - Cqvar·log (Evar)/ log (2) · 100[%]
(8)RIV1 + RIV2 = 100%
PCR-products. In contrast to gene specific fluorescent 
probes, DNA binding dyes do not limit the choice of 
primer sequences and offer high flexibility for the adapta-
tion of the method to different splice events. Since each 
amplicon may bind different amounts of dye, producing 
different fluorescence emission, in principle, an indi-
vidual proportionality constants “k” for each amplicon 
is needed for comparison [22]. These amplicon specific 
constants are unknown and may even change during the 
course of the reaction as the reporter/DNA ratio changes 
[22]. In assays using the more common comparative 
threshold cycle method, this problem is circumvented by 
comparing the same amplicon from two samples so that 
these constants are cancelled [23, 24]. This is not applica-
ble to our approach, because two different amplicons are 
compared within a single sample. However in practice, 
the influence of unequal binding of SYBR Green to ampli-
cons of different size or GC content appeared to be negli-
gible [25, 26]. Rutlege and Stewart showed for amplicons 
ranging in size from 100 to 400 bp that the fluorescence 
intensity generated by SYBR Green was independent of 
GC content and amplicon size [25]. In line with this find-
ing, Spandidos and coworkers also did not observe any 
length dependent or AT/GC dependent sequence speci-
ficity of SYBR Green when they analyzed purified ampli-
con DNA [26]. Furthermore and as discussed below, we 
included an internal control, which readily uncovers 
experimental errors including errors based on unequal 
binding of SYBR Green to amplicons.
3. SYBR Green staining also provided the basis for the 
identification of amplicons by melting curve analysis, 
which was included as third key element into our strat-
egy. Melting curve analysis is a measurement of the tem-
perature dependent dissociation of two DNA strands 
during heating. That way, the identity of the PCR product 
and the absence of off-target amplification products were 
confirmed.
4. Sample to sample variations of the integrity and 
purity of the RNA and the use of different primer pairs 
might strongly affect the efficiency of the amplification 
process. Therefore, a correction for efficiency of the cycle 
of quantification (Cq) value is indispensable [23]. We 
used Cq and efficiency values calculated with the com-
parative quantification tool (CQ) of the Rotor Gene PCR 
instrument to determine efficiency corrected Cq values 
(CqE). The comparative quantification tool is based on 
the second derivative maximum method and has been 
proposed as a convenient and accurate way to determine 
the efficiency and the Cq of PCR reactions [19, 27]. It 
uses the second derivative of raw fluorescence values—
i.e. the slope of the amplification curve—to calculate 
both, the efficiency and the take off point at which the 
exponential phase of amplification begins [19].
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5. To analyse the frequency of two splice variants by 
RT-qPCR, in principle, two primer pairs are sufficient 
[11]. However, local differences of the secondary mRNA 
structure of the splice variants may cause a disparity of 
reverse transcription and may distort the result. Further-
more, data might be biased by experimental errors (see 
above). This illustrates the need of an internal control 
(Fig. 1a). As a fifth key element of our strategy, we intro-
duced control primer combinations matching a common 
sequence of both splice variants (Fig.  1a, b). Since the 
common sequence is independent of splicing, the con-
trol primers were used to determine the total frequency 
of all variants. Their amplicon can be regarded as single 
but ideal reference (gene) since its rate is invariant and 
strictly linked to the expression of the isoforms, obviat-
ing the need for other, unrelated reference (housekeep-
ing) genes for normalization. Using the amplicons of the 
control primers for normalization, the relative incidence 
of each single variant was calculated, individually. Since 
the sum of alternatively spliced transcripts expressed 
from one gene is identical to its total number of protein 
coding transcripts, the relative incidence of the two vari-
ants should add up to 100 %. This way, the introduction 
of a control primer pair and the calculation of relative 
incidences provided an easy and efficient way to moni-
tor variations of reverse transcription and experimental 
errors.
As a model to test our approach we chose the Tran-
sient receptor potential melastatin 3 (Trpm3) gene. The 
Trpm3 gene expresses a number of splice variants, some 
of which encode ion channel proteins with considerable 
functional differences [28, 29]. Splicing of 54 nucleotides 
from Trpm3 transcripts at the 3´end of exon 13 (Fig. 1b) 
removes a protein domain that is indispensable for the 
function of TRPM3 ion channels [29]. However, TRPM3 
variants devoid of this region are ubiquitously present 
in different tissues and cell types [29]. Using a set of two 
primer pairs for RT-qPCR, we recently showed that their 
transcripts constitute 2–15 % of the TRPM3 protein iso-
forms [29].
First, we designed a boundary spanning primer (over-
lapping the splice site), which hybridized only to the 
1312
alternatively spliced part


























Fig. 1 Concept to quantify alternative splice variants. a Key elements of the RT-qPCR based strategy for the relative quantification of splice variants. 
b Scheme of the TRPM3 mRNA structure with exon 12–14 and the alternatively spliced part of exon 13. Different primer pairs and their location rela-
tive to the TRPM3 mRNA are shown as arrows. The length of their amplicons [bp] and their isoform specificity are indicated
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spliced transcript of variant 1 (Fig.  1b). The design of 
this primer was most delicate due to its limitation to 
the sequence flanking the splice junction. Special atten-
tion was taken to its length and its 3´sequence to avoid 
mispriming. This boundary spanning primer was com-
bined with a primer located outside the spliced region 
in an adjacent exon. Using this primer pair named 
∆13, one single product of 153 bp specific for variant 1 
was expected  (Fig.  1b). Second, we designed a primer 
located within the excised part of the exon to detect 
non-spliced transcripts of variant 2 (Fig. 1b). Likewise, 
the primer was combined with a primer located outside 
the spliced region (primer pair +13) to amplify one sin-
gle product of 78 bp. Third, we introduced control prim-
ers that matched to sequences common to both variants 
located outside of the spliced region. Both primers of 
control primer combination 1 were located upstream 
and close to the spliced region. They amplified identi-
cal fragments of 109 bp from both types of transcripts 
(Fig. 1b). RT-qPCR using these primers was independ-
ent of splicing because the sequence and the secondary 
structure of their target amplicon were identical in both 
TRPM3 variants. Therefore, this primer pair served 
as solid internal reference to determine relative inci-
dence values (RIV) of each single variant. To establish 
the method, these three primer pairs—one specific for 
each of the variants and one control primer pair—were 
sufficient. However, we additionally included a sec-
ond control primer pair that flanked the spliced region 
(Fig. 1b). This control primer pair 2 provided the oppor-
tunity of simultaneous detection of two distinguishable 
amplicons of 150  bp and 204  bp each specific for the 
spliced and the non-spliced variant, respectively. If the 
reverse transcription of one alternative transcript were 
impeded, the use of this primer pair would lead to mis-
calculations. Therefore, this control primer pair 2 may 
serve as internal control only if its efficiency corrected 
Cq values (CqE) match to those obtained with control 
primer pair 1.
Optimization and adjustment of PCR conditions
We tested different PCR cycling parameter such as 
primer concentration, annealing temperature and dye 
concentration with a 1:1 mixture of two plasmids encod-
ing the different splice variants. As shown in Fig.  2a, 
increasing primer concentrations up to 300  nM signifi-
cantly improved the efficiency of the reactions. At higher 
concentrations improvements were modest but the risk 
of primer dimer formation increased substantially (not 
shown). Therefore, we used 300  nM concentrations of 
each primer throughout the following experiments. The 
melting temperature Tm of each primer was calculated 
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Fig. 2 Optimization of primer concentration and annealing temperature. Efficiencies of PCRs were analysed for each primer pair in the presence of 
different primer concentrations (a) or using different annealing temperatures (b). A 1:1 mixture of two plasmids each encoding the cDNA of one of 
the two variants (1.25 pM each) served as template. Mean PCR efficiency (E) values and their SEM of three independent experiments are shown. The 
best PCR conditions are shaded in grey
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temperature, providing the most efficient amplification of 
each primer combination, was 68 °C (Fig. 2b).
Control primers 2, flanking the spliced region, ampli-
fied two fragments of different length, each specific for 
one splice variant (Fig.  1b). Their amplicons could be 
distinguished by gel electrophoresis or by melting curve 
analysis. Using these tools, we could easily verify that 
all primer pairs amplified the desired products without 
mispriming or primer dimer formation. Using control 
primer pair 2, we found two discriminable peaks in the 
melting curve (Fig. 3a). Sequencing of the fragments con-
firmed their identity (data not shown). SYBRGreenER 
has been suggested by the manufacturer to be less inhibi-
tory and to provide higher specificity than SYBR Green. 
Consistently, we detected two clearly separated peaks 
when we performed RT-qPCR in the presence of SYBR-
GreenER (Fig.  3a) indicating its superiority for melting 
curve analysis.
Although SYBRGreenER displayed a better resolution 
in melting curve analysis, we asked, if the more common 
dye SYBR Green may be sufficient for our application, 
or if its inhibitory effect on PCR [30] or its preferential 
binding to specific DNA sequences [31] may limit its use. 
Using control primer pair 2 and different SYBR Green 
concentrations, we determined the cycle of quantifica-
tion (Cq) and the PCR efficiency (E) and calculated the 
efficiency corrected Cq (CqE, Fig.  3b, c). Values were 
compared to those obtained with control primers 1. 
Increasing dye concentrations led to slightly elevated Cq 
values, most likely due to inhibition of the PCR by SYBR 
Green. The steepest amplification curves, the strong-
est fluorescence signals, and the best efficiencies were 
obtained with the onefold concentrated dye (1×). The 
amplification curves obtained with both control primer 
pairs were highly congruent (Fig.  3b) and revealed very 
similar Cq, E and CqE values (Fig.  3c), indicating that 
SYBR Green is sufficient for our application. Further-
more, the experiment already suggested that both primer 
pairs could serve as control for the quantification of 
splice events with variant specific primers. However, 
when we tested the control primers 2 in the presence of 
the twofold concentrated dye (2×) we observed a strong 
distortion of the amplification curve leading to efficiency 
values above 2 and an non-proportional increase of the 
Cq value (Fig. 3c). Therefore, care should be taken not to 
exceed the limit of a onefold concentration.
Range and resolution of detection
Since the method should be applicable to a broad range 
of template concentrations, we tested tenfold serial dilu-
tions of two equimolar concentrated plasmids encoding 
the two different variants. First, we analysed the range of 




















































CqEPrimer pair Cq E
11.42control2 11.1 2.04
control1 9.7 1.95 9.35
8.20control2 9.4 1.83
control1 9.4 1.84 8.27
control2 8.8 1.74 7.03
control1 8.9 1.75 7.19
control2 8.6 1.71 6.66













Fig. 3 SYBR Green is suitable to analyse alternative splicing by RT-
qPCR. a Melting curve analysis of the two variant specific fragments 
amplified with control primers 2 from mRNA transcripts expressed 
in the choroid plexus of mouse brain in the presence of onefold 
concentrated (1 ×) SYBR Green or SYBRGreenER. b Amplification 
curves using a 1:1 mixture of two plasmids containing the cDNA 
of variants 1 and 2 (1.25 pM each) in the presence of different SYBR 
Green concentrations. Dye concentrations are indicated as multiples 
of the concentration recommended by the supplier, since it was 
impossible to obtain detailed information about the molarity of the 
dye in the reagent. Dashed lines show the mean of three reactions 
using control primer pair 1, solid lines using control primer pair 2. 
c The cycle of quantification (Cq) and the PCR efficiency (E) of the 
amplification curves shown in C were obtained from the comparative 
quantitation tool of the Rotorgene software and efficiency corrected 
Cq values (CqE) were calculated as described [18]. All curves, the Cq 
and E values are means of triplicates. Experiments were performed 
thrice with similar result
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highly similar amplification plots and relative stand-
ard curves (Fig. 4a), indicating a high specificity of both 
primer pairs in a range of template concentrations span-
ning five orders of magnitude. Next, we analysed the two 
control primer pairs, and again we obtained highly con-
gruent amplification curves (Fig. 4b). The corresponding 
standard curves displayed linearity with correlation coef-
ficients higher than 0.99. Using the slopes of the standard 
curves, we calculated amplification efficiencies (E) close 
to 1.9, confirming the specificity and applicability of both 
control primer pairs (Fig. 4b).
The method should also enable the detection of small 
changes of the ratio of variants. Therefore, we analysed 
the resolution of the method using the control primer 
pairs 1 and 2 and a twofold serial dilution of a plasmid 
mixture containing 108 copies of both templates. We 
obtained overlapping amplification curves for the two 
primer pairs that were clearly separated for each dilu-
tion. The standard curves were almost identical and lin-
ear, indicating that even small changes of the template 
concentration were equally detectable with both control 
primer pairs (Fig.  5a). The efficiencies determined from 
these standard curves were used to calculate the num-
bers of copies that served as templates in the reactions. 
Regardless of whether we used control primer pair 1 or 
control primer pair 2, the calculated values correlated 
with the copy numbers introduced into the reactions 
(Fig.  5b, blue bars), demonstrating the resolving capac-
ity of the method. The generation of standard curves is 
labour intensive and relative quantification using stand-
ard curve derived efficiencies may provide less reliable 























































































































Fig. 4 Range of detection of the assay. Amplification curves obtained with primer pair +13 (solid lines in a) primer pair Δ13 (dashed lines in a), 
control primer pair 2 (solid lines in b) or control primer pair 1 (dashed lines in b) and different copy numbers of both cDNA templates in equimolar 
ratio shown as means of triplicates performed thrice with similar results. The corresponding standard curves are presented on the right. Correlation 
coefficient (R2), slope (M), y-intercept (B) and amplification efficiencies (E) calculated with the equation E = 10−1/M are indicated
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20, 32, 33]. Therefore, we repeated the calculation with 
efficiency values supplied by the comparative quantita-
tion tool of the Rotorgene software (Fig.  5b red bars). 
Comparing the two procedures, we found no significant 
differences of the mean values and their corresponding 
standard errors indicating that both methods of calcula-
tion yielded credible data.
To confirm these findings, we simulated changes of the 
ratio of the variants and applied the method to mixtures 
containing the two cDNA templates in ratios of 1:9, 1:3, 
1:1, 3:1 and 9:1. Using primer pair 2 we found amplifi-
cation products of the expected size representing the 
two different splice variants (Figs.  3a, 6a). We analysed 
the data using different tools to estimate amplification 
efficiencies (Fig. 6b). Efficiency corrected Cq values (CqE) 
obtained with primer pairs +13, Δ13 and control1 were 
calculated and the starting amounts of their amplicons 
were normalized to those obtained with control primer 
pair 2 to determine relative incidence values (RIV) of the 
transcripts. The RIVs determined with control primer 
pair 1 were close to 100  %, indicating again that the 
amplicons of both control primer combinations could be 
used for normalization. The RIVs obtained with variant 
specific primers displayed linear relationships with highly 
similar absolute values of the slopes, indicating that these 
values indeed mirror the relative incidence of the vari-
ants. Furthermore, these RIVs added up to values close 
to 100 % (Fig. 6c), confirming the principle of the method 





















































































Fig. 5 Resolution of the assay. a Amplification curves obtained with control primer pair 1 (dashed lines) or control primer pair 2 (solid 
lines) and different copy numbers of both templates present in equimolar ratio shown as means of triplicates performed in independ-
ent experiments with similar results (n = 5). The corresponding standard curves are shown on the right. Correlation coefficient (R2), slope 
(M), y-intercept (B) and amplification efficiencies (E) calculated with the equation E = 10−1/M are indicated. b Copies obtained in different 







· 108 = 2Cqz·log(Ez)/ log (2) - Cqx·log(Ex)/ log (2) · 108 with Cqz and Ez = Cq and E values obtained with control primer pair 
2 and 108 introduced copies. The efficiencies introduced into the equation were obtained either from the comparative quantitation tool of the 
Rotorgene software (red columns) or the standard curves shown in A (blue columns). Dark columns represent reactions using control primer pair 2, 
light columns control primer 1. Mean values ± SE of five independent experiments each performed in triplicate are presented
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and its reliability. Using the comparative analysis tool of 
the Rotorgene software, the sum of variant specific RIVs 
deviated only slightly from 100 % and the RIV obtained 
with control primer pair 1 (Fig.  6c). Here, a maximal 
deviation Dmax of 7 % was observed in mixture M1 and 
the mean of the deviations Dmean was 2.7 %. Using stand-
ard curves (S.C.) or the LinReg Program (L.R.) to calcu-
late amplification efficiencies we found somewhat larger 
deviations of the sum of variant specific RIVs (S.C.: Dmax 
11.5 %, Dmean 9.0 %; L.R.: Dmax 7.2 %, Dmean 4.5 %), indi-
cating that determination of amplification efficiencies 
using the comparative analysis tool of the Rotorgene 
software may be not only sufficient but even superior to 
standard curves.
Detection and relative quantification of splice variants 
in tissues
We used different RNA preparations from mouse tis-
sues, which were reported to express TRPM3 [28] to test 
the accuracy and the reliability of the method. Using the 
control primer pair 2 we initially checked, whether in a 
relevant tissue both variants were detectable. As shown 
in Fig. 7a, we found both variants present in total RNA 
prepared from mouse brain as well as from the choroid 
plexus of the brain. Next, we compared the amplification 
curves obtained with the two control primer pairs and 
found them overlapping (Fig. 7b), indicating that reverse 
transcription of the variant transcripts was highly simi-
lar. Accordingly, we calculated RIVs of 98 and 99 % using 
control primer pair 1 (Fig. 7c). Using the primer pair +13, 
we determined a relative incidence of variant 2 of 83 and 
81  % in brain and choroid plexus, respectively. Corre-
spondingly, when we performed the analysis with primer 
pair Δ13, we found that 14 and 20  % of the transcripts 
encoded variant 1. The Sum of the RIVs of the two vari-
ants totalled up to 97 % for brain and 101 % for choroid 
plexus, confirming the correctness of the data and dem-
onstrating again that the sum of the relative incidences is 
a useful control of the procedure.
Conclusions
The presented data confirm our methodological concept 
and demonstrate that the method is robust and sensi-
tive enough to detect even small changes of the ratio of 
alternatively spliced transcripts that arise from splicing 
at a single splice site. However, the method is limited to 
variant1
variant2
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Fig. 6 qPCR analysis of different ratios of cDNA variant 1 and 2. a Gel 
electrophoretic separation of amplification products obtained with 
control primer pair 2 and two plasmids encoding the cDNA of either 
variant2 or variant1 mixed in five different molar ratios M1– M5 as 
indicated. b Quantification of the different templates in the mix-
tures M1– M5 presented in A using four different primer pairs. PCR 
efficiencies (E) were determined using either standard curves (S.C.), 
the comparative quantitation tool of the Rotor gene software (C.Q.) 
or using non-baseline corrected data and the LinRegPCR software 
(L.R). Values for the relative incidences (RIV) of transcripts (x) were 
calculated using Cq values (Cqx) and E values (Ex) obtained with the 
control primer pair 1 (filled circles), primer pair +13, (open squares) 







· 100[%] = 2Cqcon2·Econ2/ log (2) - Cqx·log(Ex)/ log (2) · 100[%]. 
Data of n = 6 independent experiments for M1–M3, n = 5 independ-
ent experiments for M4 and n = 8 independent experiments for M5 
are shown with each reaction performed in triplicate. Statistical sig-
nificance of differences to the starting amount of control2 amplicons 
(defined as 100 %) were tested using the unpaired two-tailed students 
t-test (*p < 0.05, **p < 0.01, ***p < 0.001, ns not significantly different 
p > 0.05). Linear regression analysis revealed correlation coefficients of 
at least 0.98 and slopes (M) as indicated. c Sum of the variant specific 
RIVs shown in b and their difference (D) to 100 %
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quantification of such single splice events and does not 
allow the simultaneous quantification of multiple splice 
events within one primary transcript. Thus, the method 
is not recommended to compare isoforms that differ at 
several regions but rather to analyse the abundance of 
isoforms with a single defined variation. In contrast to 
RT-qPCR based analysis of the relative expression of 
various genes in different samples, our method does not 
allow to compare the abundance of mRNA isoforms in 
different samples, but to analyse the ratio of two mutu-
ally exclusive transcripts within a single sample, provid-
ing important information about splicing frequencies and 
the relative incidence of the encoded protein isoforms. 
The method is easy to perform and provides great flex-
ibility regarding the choice of the primer sequences. 
It can be applied to most splice events and to a broad 
range of template concentrations and ratios. In addition, 
the method allows to monitors experimental errors and 
variations of reverse transcription of the different tran-
scripts and to simultaneously detect two distinguish-
able, isoform specific products in one single reaction. 
The method considers different amplification efficiencies 
of the primer pairs and determines molar ratios of two 
alternatively spliced transcripts up to 1:9. It is therefore 
a simple and reliable tool to analyse the incidence and 
relative changes of two splice variants. Its simplicity and 
reliability may facilitate its translation to clinical diagnos-
tics of diseases with altered ratio of alternatively spliced 
RNAs e.g. frontotemporal dementia and Parkinsonism 
linked to chromosome 17 (FTDP-17) [3].
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